{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:50:48Z","timestamp":1776387048029,"version":"3.51.2"},"reference-count":47,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 R01 HL126903\u201002"],"award-info":[{"award-number":["5 R01 HL126903\u201002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypertension among patients on hemodialysis is common, difficult to diagnose and often inadequately controlled. Although specific blood pressure (<jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>) targets in this particular population are not yet established, meta\u2010analyses of randomized trials showed that deliberate <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>\u2010lowering with antihypertensive drugs improves clinical outcomes in hemodialysis patients. <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>\u2010lowering in these individuals should initially utilize nonpharmacological strategies aiming to control sodium and volume overload. Accordingly, restricting dietary sodium intake, eliminating intradialytic sodium gain via individualized dialysate sodium prescription, optimally assessing and managing dry\u2010weight and providing a sufficient duration of dialysis are first\u2010line treatment considerations to control <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>. If <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> remains uncontrolled despite the adequate management of volume, antihypertensive therapy is the next consideration. Contrary to nonhemodialysis populations, emerging clinical\u2010trial evidence suggests that among those on hemodialysis, \u03b2\u2010blockers are more effective than agents blocking the renin\u2010angiotensin\u2010system (<jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>) in reducing <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> levels and protecting from serious adverse cardiovascular complications. Accordingly, \u03b2\u2010blockade is our first\u2010line approach in pharmacotherapy of hypertension. Long\u2010acting calcium\u2010channel\u2010blockers and <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>\u2010blockers are our next considerations, taking into account the comorbidities and the overall risk profile of each individual patient. Additional research efforts, mainly randomized trials, are clearly warranted in order to elucidate aspects of management that remain elusive in hypertensive dialysis patients.<\/jats:p>","DOI":"10.1111\/sdi.12741","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T11:37:15Z","timestamp":1533641835000},"page":"557-562","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Blood pressure control in conventional hemodialysis"],"prefix":"10.1111","volume":"31","author":[{"given":"Panagiotis I.","family":"Georgianos","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension 1st Department of Medicine AHEPA Hospital Aristotle University of Thessaloniki Thessaloniki Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Medicine Indiana University School of Medicine and Richard L. Roudebush Veterans Administration Medical Center Indianapolis Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00366-8"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000331067"},{"issue":"3","key":"e_1_2_6_4_1","first-page":"211","article-title":"Blood pressure and mortality in long\u2010term hemodialysis\u2010time to move forward","volume":"30","author":"Georgianos PI","year":"2017","journal-title":"Am J Hypertens"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000154895.18269.67"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70188-5"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.144899"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02250507"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00107.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04334"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09091"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000359"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.128116"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60212-9"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017020135"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00870116"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.129"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907355"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03360807"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2009.00641.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.125674"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs597"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.07.003"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-011-0427-z"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001657"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl293"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.04.031"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs590"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.69"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.105"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01068-3"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1159\/000435842"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00241-9"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft515"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09981014"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.10.029"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn304"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001983"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.1.105"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570161115666170201113817"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.09.056"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12628"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.04.011"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12371214"},{"key":"e_1_2_6_46_1","unstructured":"University Hospital Brest: NCT01848639: ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST). ClinicalTrials.gov U.S. National Institutes of Health 2013 2015."},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2009.00697.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.469"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fsdi.12741","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/sdi.12741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T19:39:53Z","timestamp":1694461193000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/sdi.12741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1111\/sdi.12741"],"URL":"https:\/\/doi.org\/10.1111\/sdi.12741","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"2018-08-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}